Medication Guide App

GSI (Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg)

Generic Name: emtricitabine/rilpivirine/tenofovir

Pill imprint GSI has been identified as Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg.

Complera is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for GSI (Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg)

Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg GSI
Complera
Generic Name:
emtricitabine/rilpivirine/tenofovir
Imprint:
GSI
Strength:
emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Gilead Sciences, Inc.

View Details Print Page

More about Complera (emtricitabine / rilpivirine / tenofovir)

Consumer resources

Professional resources

Compare with other treatments for:

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)